Morgan Stanley’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.39M | Sell |
775,258
-584,627
| -43% | -$2.48M | ﹤0.01% | 4643 |
|
|
2025
Q4 | $4.91M | Sell |
1,359,885
-131,164
| -9% | -$572K | ﹤0.01% | 4186 |
|
|
2025
Q3 | $5.62M | Buy |
1,491,049
+655,642
| +78% | +$2.53M | ﹤0.01% | 4061 |
|
|
2025
Q2 | $3.23M | Buy |
835,407
+178,160
| +27% | +$964K | ﹤0.01% | 4394 |
|
|
2025
Q1 | $3.29M | Sell |
657,247
-264,575
| -29% | -$1.68M | ﹤0.01% | 4265 |
|
|
2024
Q4 | $6.65M | Sell |
921,822
-373,763
| -29% | -$2.86M | ﹤0.01% | 3749 |
|
|
2024
Q3 | $7.95M | Buy |
1,295,585
+4,565
| +0.4% | +$30.9K | ﹤0.01% | 3608 |
|
|
2024
Q2 | $8.59M | Sell |
1,291,020
-920,928
| -42% | -$6.8M | ﹤0.01% | 3431 |
|
|
2024
Q1 | $22.5M | Buy |
2,211,948
+130,146
| +6% | +$1.32M | ﹤0.01% | 2561 |
|
|
2023
Q4 | $23.4M | Buy |
2,081,802
+1,597,744
| +330% | +$6.67M | ﹤0.01% | 3197 |
|
|
2023
Q3 | $1.26M | Sell |
484,058
-596,540
| -55% | -$1.71M | ﹤0.01% | 4661 |
|
|
2023
Q2 | $3.81M | Buy |
1,080,598
+295,077
| +38% | +$1.32M | ﹤0.01% | 3966 |
|
|
2023
Q1 | $3.31M | Buy |
785,521
+350,937
| +81% | +$4.17M | ﹤0.01% | 4106 |
|
|
2022
Q4 | $7.15M | Sell |
434,584
-157,326
| -27% | -$1.77M | ﹤0.01% | 3411 |
|
|
2022
Q3 | $7.56M | Sell |
591,910
-782,114
| -57% | -$11.5M | ﹤0.01% | 3268 |
|
|
2022
Q2 | $16.1M | Sell |
1,374,024
-33,915
| -2% | -$209K | ﹤0.01% | 2521 |
|
|
2022
Q1 | $8.57M | Buy |
1,407,939
+255,596
| +22% | +$1.88M | ﹤0.01% | 3088 |
|
|
2021
Q4 | $10.6M | Buy |
1,152,343
+430,539
| +60% | +$4.57M | ﹤0.01% | 2897 |
|
|
2021
Q3 | $8.16M | Sell |
721,804
-53,724
| -7% | -$653K | ﹤0.01% | 3133 |
|
|
2021
Q2 | $7.64M | Buy |
775,528
+697,988
| +900% | +$9.54M | ﹤0.01% | 3302 |
|
|
2021
Q1 | $1.1M | Buy |
77,540
+10,753
| +16% | +$174K | ﹤0.01% | 4667 |
|
|
2020
Q4 | $753K | Buy |
66,787
+39,429
| +144% | +$465K | ﹤0.01% | 4824 |
|
|
2020
Q3 | $361K | Buy |
27,358
+7,872
| +40% | +$157K | ﹤0.01% | 4800 |
|
|
2020
Q2 | $209K | Buy |
19,486
+11,764
| +152% | +$64.6K | ﹤0.01% | 5056 |
|
|
2020
Q1 | $25K | Buy |
7,722
+2,074
| +37% | +$4.77K | ﹤0.01% | 5724 |
|
|
2019
Q4 | $11K | Sell |
5,648
-155
| -3% | -$286 | ﹤0.01% | 6240 |
|
|
2019
Q3 | $11K | Sell |
5,803
-123,990
| -96% | -$275K | ﹤0.01% | 6166 |
|
|
2019
Q2 | $309K | Buy |
+129,793
| New | +$347K | ﹤0.01% | 4832 |
|
|
2019
Q1 | – | Sell |
-4,693
| Closed | -$10K | – | 6581 |
|
|
2018
Q4 | $10K | Sell |
4,693
-3,882
| -45% | -$13.7K | ﹤0.01% | 6155 |
|
|
2018
Q3 | $38K | Buy |
8,575
+8,568
| +122,400% | +$93.3K | ﹤0.01% | 5950 |
|
|
2018
Q2 | $0 | Sell |
7
-1
| -13% | -$20 | ﹤0.01% | 6655 |
|
|
2018
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 6600 |
|
|
2017
Q4 | $0 | Sell |
8
-127
| -94% | -$8.11K | ﹤0.01% | 6558 |
|
|
2017
Q3 | $10K | Sell |
135
-34
| -20% | -$2.53K | ﹤0.01% | 6166 |
|
|
2017
Q2 | $16K | Sell |
169
-111
| -40% | -$18.5K | ﹤0.01% | 6136 |
|
|
2017
Q1 | $68K | Sell |
280
-501
| -64% | -$268K | ﹤0.01% | 5738 |
|
|
2016
Q4 | $760K | Buy |
781
+736
| +1,636% | +$659K | ﹤0.01% | 4662 |
|
|
2016
Q3 | $39K | Buy |
45
+35
| +350% | +$27.5K | ﹤0.01% | 5684 |
|
|
2016
Q2 | $7K | Buy |
10
+3
| +43% | +$2.05K | ﹤0.01% | 6141 |
|
|
2016
Q1 | $4K | Hold |
7
| – | – | ﹤0.01% | 6312 |
|
|
2015
Q4 | $4K | Hold |
7
| – | – | ﹤0.01% | 6405 |
|
|
2015
Q3 | $3K | Hold |
7
| – | – | ﹤0.01% | 6442 |
|
|
2015
Q2 | $4K | Sell |
7
-45
| -87% | -$22.7K | ﹤0.01% | 6440 |
|
|
2015
Q1 | $25K | Sell |
52
-28
| -35% | -$14K | ﹤0.01% | 5992 |
|
|
2014
Q4 | $43K | Buy |
80
+57
| +248% | +$29.3K | ﹤0.01% | 5854 |
|
|
2014
Q3 | $12K | Sell |
23
-260
| -92% | -$136K | ﹤0.01% | 6141 |
|
|
2014
Q2 | $120K | Buy |
283
+191
| +208% | +$86.3K | ﹤0.01% | 5411 |
|
|
2014
Q1 | $51K | Sell |
92
-8
| -8% | -$4.67K | ﹤0.01% | 5702 |
|
|
2013
Q4 | $56K | Buy |
100
+42
| +72% | +$25.1K | ﹤0.01% | 5554 |
|
|
2013
Q3 | $36K | Buy |
+58
| New | +$33.2K | ﹤0.01% | 5232 |
|
Other funds holding ALT
VCM
VPM
N
Morgan Stanley's ALT Position: Q1 2026 in Review
Morgan Stanley reduced its Altimmune (ALT) stake by 43% in Q1 2026, selling an estimated $2.48M and leaving 775,258 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #4643.
Morgan Stanley first reported a position in ALT in Q3 2013 and has held it in 50 quarters since. The position peaked at $23.4M in Q4 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.
- Morgan Stanley held 775,258 shares of Altimmune worth $2.39M as of Q1 2026.
- Morgan Stanley sold 584,627 Altimmune shares in Q1 2026, an estimated $2.48M.
- Altimmune made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4643 holding.
- Morgan Stanley first reported a position in Altimmune in Q3 2013 and has held it in 50 quarters since.
- Morgan Stanley's Altimmune position peaked at $23.4M in Q4 2023.
- 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.